Back to mobile site

Abbvie (ABBV) PT Raised to $300 at Wells Fargo

August 17, 2026 6:26 AM EDT Send to a Friend
Wells Fargo analyst Mohit Bansal raised the price target on Abbvie (NYSE: ABBV) to $300.00 (from $295.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login